Home / Business / Investment That Totally Worth It: Guess’, Inc. (NYSE:GES), Chico’s FAS Inc. (NYSE:CHS)

Investment That Totally Worth It: Guess’, Inc. (NYSE:GES), Chico’s FAS Inc. (NYSE:CHS)

Guess’, Inc. (NYSE:GES) runs in leading trade, it an ascending 22.15% to traded at $18.20. GES attains analyst recommendation of 3.00 on scale of 1-5 with week’s performance of 17.80%.  The apparel and accessories company, Guess Inc. (GES) reported that it fiscal Q2 earnings and same-store sales that beat consensus. Net income for the quarter totaled $32.3 million, or 38 cents per share, up from $18.3 million, or 21 cents per share, for the same period last year.

Adjusted earnings were 14 cents per share, beating the FactSet consensus of 6 cents per share. Sales totaled $545.0 million, down from $546.3 million, and below the $551.0 million FactSet consensus. Same-store sales for the Americas retail segment, including e-commerce, fell 2%, compared with the FactSet estimate of a 4.3% decline.

To find out the technical position of GES, it holds price to book ratio of 1.51 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. It has forward price to earnings ratio of 21.85, and price to earnings ratio calculated as 29.12. The price to earnings growth ration calculated as 6.62.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -13.10%, and looking further price to next year’s EPS is 39.07%. While take a short look on price to sales ratio, that was 0.69 and price to earning ration of 29.12 attracting passive investors.

Chico’s FAS Inc. (NYSE:CHS) kept active in under and overvalue discussion, CHS holds price to book ratio of 2.52 that presents much better indicator to find market price of a share price over its book value of equity for investment valuation. In addition, the firm has price to earnings ratio of 588.00, which is authentic method to judge but not universal for all situation.

Fundament/ News Factor in Focus

Taking look on ratio analysis, CHS has forward price to earnings ratio of 14.89, compare to its price to earnings ratio of 588.00. Adding one more ration to find detail valuation of security, price to earnings growth ration that stands at 47.92. The co is presenting price to cash flow as 14.57 and the low single digit may indicate stock is undervalued and vise versa. On other hand, keeping in mind stable cash flows but few growth prospects make traders to value lower.

The firm has price volatility of 2.30% for a week and 2.88% for a month. Its beta stands at 0.89 times. Narrow down four to firm performance, its weekly performance was -0.84% and monthly performance was -2.16%.


About Devon Leftovich

Devon Leftovich is an entrepreneur. He has been writing and editing professionally for over six years. He is admin editor and senior content writer of SWR. However, he has determined to give investors something rare, a dignified partner who can manage money with integrity and a clear conscience about the degree of due diligence behind investment decisions. He said, "I love the financial world because it is like one big puzzle and I hope we the SWR help each other out to solve the puzzle to help us realize our dreams." Interests: Analysis of different Companies; including news and analyst rating updates. He performs analysis of Companies and publicizes important information for investor/traders community. Stocks long-term and short-term holding views, Tech Stocks

Check Also

EPS Estimates Lure Passive Investments: Opko Health, Inc. (NASDAQ:OPK), RXi Pharmaceuticals (NASDAQ:RXII)

Opko Health, Inc. (NASDAQ:OPK) [Trend Analysis] try to make new thrust in street and making …

Leave a Reply

Your email address will not be published. Required fields are marked *